Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 3;7(18):26192-205.
doi: 10.18632/oncotarget.8353.

Prognostic value and clinicopathologic characteristics of L1 cell adhesion molecule (L1CAM) in a large series of vulvar squamous cell carcinomas

Affiliations

Prognostic value and clinicopathologic characteristics of L1 cell adhesion molecule (L1CAM) in a large series of vulvar squamous cell carcinomas

Marjolijn D Trietsch et al. Oncotarget. .

Abstract

Background: Vulvar cancer treatment is mostly curative, but also has high morbidity rates. In a search for markers that can identify patients at risk of metastases, we investigated the prognostic value of L1-cell adhesion molecule (L1CAM) in large series of vulvar squamous cell carcinomas (VSCCs). L1CAM promotes cell motility and is an emerging prognostic factor for metastasis in many cancer subtypes.

Results: L1CAM expression was observed at the invasive front or in spray-patterned parts of 17% of the tumours. L1CAM-positive tumours expressed vimentin more often, but L1CAM expression was not associated with TP53 or CTNNB1 mutations. Five-year survival was worse for patients with L1CAM expression (overall survival 46.1% vs 63.6%, P=.014, disease specific survival 63.8% vs 80.0%, P=.018). Multivariate analysis indicates L1CAM expression as an independent prognostic marker (HR 2.9, 95% CI 1.10-7.68). An in vitro spheroid invasion assay showed decreased invasion of L1CAM-expressing VSCC spindle cells after treatment with L1CAM-neutralising antibodies.

Methods: Paraffin-embedded tumour tissue from two cohorts (N=103 and 245) of primary VSCCs were stained for L1CAM, vimentin and E-cadherin. Patients of the first cohort were tested for human papilloma virus infection and sequenced for TP53 and CTNNB1 (β-catenin) mutations. The expression of L1CAM was correlated to clinical characteristics and patient survival.

Conclusion: This is the first study to show high L1CAM-expression at the infiltrating margin of VSCC's. L1CAM-expressing VSCCs had a significantly worse prognosis compared to L1CAM-negative tumours. The highest expression was observed in spindle-shaped cells, where it might be correlated to their invasive capacity.

Keywords: L1 cell adhesion molecule; L1CAM; squamous cell carcinoma; survival; vulvar cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1. L1CAM expression
Two vulvar squamous cell carcinomas with spindle cell morphology (A and B) and solid growth pattern (C and D) stained for keratin (A and C) and L1CAM (B and D). Arrowhead: nerve axon as an internal positive control.
Figure 2
Figure 2. Survival curves
Kaplan meier survival curves for the leiden cohort, n=103 A, B. and both cohorts combined, n=348 C, D. P-values for log-rank test.
Figure 3
Figure 3. Spheroid invasion assay
A. Spindle shaped cells highly express L1CAM, while L1CAM expression on cobble shaped cells is very low. B. Spindle and cobble cells form spheroids equally well and invade when embedded in a collagen matrix (C. and D.). Note that the invasion of the non-L1CAM expressing cobble shaped cells (C) is hardly affected by L1CAM neutralising antibodies, while spindle cell invasion can be strongly inhibited by the L1CAM neutralising antibodies (D)

Similar articles

Cited by

References

    1. Dittmer C, Fischer D, Diedrich K, Thill M. Diagnosis and treatment options of vulvar cancer: a review. Arch Gynecol Obstet. 2012;285:183–93. - PubMed
    1. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gyneco.l. 2006;107:1018–22. - PubMed
    1. Hacker NF. Vulvar Cancer. In: Berek JS, Hacker NF, editors. Practical gynecologic oncology. 3. Philadelphia: Lippincott Williams & Wilkins; 2005. pp. 543–76.
    1. van de Nieuwenhof HP, Massuger LF, van der Avoort IA, Bekkers RL, Casparie M, Abma W, van Kempen LC, de Hullu JA. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur J Cancer. 2009;45:851–6. - PubMed
    1. Del Pino M, Rodriguez-Carunchio L, Ordi J. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Histopathology. 2013;62:161–75. - PubMed

Substances